The neonatal period represents a critical window of increased neurodevelopmental plasticity in the immature nervous system. Unlike other sensory modalities, which require appropriate stimulation for proper development, maturation of nociceptive circuitry in neonates typically occurs in the absence of noxious stimulation. Premature infants, however, are routinely exposed to multiple invasive medical procedures during neonatal intensive care treatment, which are largely performed in the absence of anesthetics or analgesics. To date, it is largely unknown how exposure to early noxious insult during this time of increased plasticity alters the development of the CNS and influences future nociceptive responses. As previous studies examining the impact of neonatal inflammatory insult on adult nociceptive responses have been conducted primarily in males, the potential adverse effects in females are unknown. Furthermore, the biological mechanisms underlying neonatal insult-induced deficits in nociceptive processing have yet to be elucidated. Therefore, this dissertation addressed the following questions: (1) Does neonatal inflammatory insult differentially alter male and female baseline somatosensory thresholds and response to re-inflammation in adulthood?; (2) Are neonatal inflammation-induced deficits in nociceptive responsiveness mediated by a potentiation in endogenous opioid tone?; and (3) Does pre-emptive morphine analgesia attenuate the behavioral consequences of neonatal inflammatory insult? Collectively, these studies will provide valuable information about the long-term consequences of neonatal noxious stimulation in males and females, which may lead to improved understanding and prevention of the lasting effects of repeated invasive interventions in premature infants in the NICU.

Morphine is the most widely prescribed opiate for alleviation of persistent pain; however, it is becoming increasingly clear that morphine is less potent in women compared to men. Morphine primarily binds mu opioid receptors, which are densely localized in the midbrain periaqueductal gray (PAG). Anatomical and physiological studies conducted in the 1960s identified the PAG, and its projections to the rostral ventromedial medulla (RVM) and spinal cord dorsal horn, as an essential neural circuit mediating opioid-based analgesia. Remarkably, the majority of studies since then were conducted in males with the implicit assumption that this circuit was the same in females; this is not the case. It is now well established that morphine produces greater analgesia in males compared to females in a wide range of vertebrates, however, the mechanism(s) driving this sex difference is not clear. Our recent studies indicate that two factors appear to be contributing to the sexually dimorphic effects of morphine. First, there are sex differences in the anatomy and physiology of the descending inhibitory pathway on which morphine acts to produce analgesia. Specifically, the projections from the PAG to the RVM are sexually dimorphic and activated to a greater degree by both inflammatory pain and systemic morphine in males. In the absence of pain, the PAG-RVM circuit is activated to a greater degree in males compared to females, while this activation steadily declines during the development of tolerance in males only. We also have evidence of a sexually dimorphic expression of mu opioid receptor within the PAG that appears to contribute to sex differences in morphine potency. Microinjection of morphine directly into the PAG produces significantly greater analgesia in males, indicating that the PAG is sufficient for eliciting this sexually dimorphic behavior. Furthermore, mu opioid receptor-expressing PAG neurons are necessary for eliciting a sexually dimorphic response to morphine as lesioning mu opioid receptor-expressing neurons attenuates analgesia in males only. Together, these data indicate that the PAG-RVM pathway and mu opioid receptor expression in the PAG is sexually dimorphic and provides a primary mechanism for sex differences in morphine potency.

Morphine is the most widely prescribed opiate for alleviation of persistent pain; however, it is becoming increasingly clear that morphine is less potent in women compared to men. Morphine primarily binds mu opioid receptors, which are densely localized in the midbrain periaqueductal gray (PAG). Anatomical and physiological studies conducted in the 1960s identified the PAG, and its projections to the rostral ventromedial medulla (RVM) and spinal cord dorsal horn, as an essential neural circuit mediating opioid-based analgesia. Remarkably, the majority of studies since then were conducted in males with the implicit assumption that this circuit was the same in females; this is not the case. It is now well established that morphine produces greater analgesia in males compared to females in a wide range of vertebrates, however, the mechanism(s) driving this sex difference is not clear. Our recent studies indicate that two factors appear to be contributing to the sexually dimorphic effects of morphine. First, there are sex differences in the anatomy and physiology of the descending inhibitory pathway on which morphine acts to produce analgesia. Specifically, the projections from the PAG to the RVM are sexually dimorphic and activated to a greater degree by both inflammatory pain and systemic morphine in males. In the absence of pain, the PAG-RVM circuit is activated to a greater degree in males compared to females, while this activation steadily declines during the development of tolerance in males only. We also have evidence of a sexually dimorphic expression of mu opioid receptor within the PAG that appears to contribute to sex differences in morphine potency. Microinjection of morphine directly into the PAG produces significantly greater analgesia in males, indicating that the PAG is sufficient for eliciting this sexually dimorphic behavior. Furthermore, mu opioid receptor-expressing PAG neurons are necessary for eliciting a sexually dimorphic response to morphine as lesioning mu opioid receptor-expressing neurons attenuates analgesia in males only. Together, these data indicate that the PAG-RVM pathway and mu opioid receptor expression in the PAG is sexually dimorphic and provides a primary mechanism for sex differences in morphine potency.

Thesis (Ph.D.)--University of Florida, 2004. / Typescript. Title from title page of source document. Document formatted into pages; contains 127 pages. Includes Vita. Includes bibliographical references.

Thesis (Ph. D.)--University of Missouri-Columbia, 2006. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. "December 2006" Includes bibliographical references.

As reações incondicionadas de defesa observadas em mamíferos são organizadas pelo Sistema Encefálico de Aversão (SEA), composto, entre outras estruturas, pela substância cinzenta periaquedutal dorsal (SCPd) e o colículo inferior (CI). Tem sido proposto que o CI seja parte do circuito sensoriomotor para os estímulos auditivos de natureza aversiva e a SCPd como a principal via de saída (output) do SEA para a elaboração de comportamentos defensivos. Ambas as estruturas são reguladas tonicamente pelo neurotransmissor inibitório ácido gama-aminobutírico (GABA). Este trabalho aborda a mediação química GABA/Benzodiazepínica (BZD) do processamento da informação aversiva no CI e das respostas de medo elaboradas pela SCPd. Grupos independentes de animais submetidos ao implante de quimitrodos (eletrodos acoplados a cânulas-guia para injeção de drogas) foram usados para avaliar no CI e SCPd os efeitos de injeções locais de muscimol (agonista de receptores GABA-A), semicarbazida (inibidor da síntese da enzima precursora do GABA descarboxilase do ácido glutâmico) ou midazolam (agonista BZD). Foram registrados potenciais evocados auditivos (PEA) no CI como medida eletrofisiológica da ativação neuronial, além da determinação dos limiares de congelamento e fuga, com o procedimento de estimulação elétrica (EE), tanto do CI quanto da SCPd. A mesma abordagem farmacológica com injeções de drogas intra-CI foi empregada em animais submetidos ao teste do Labirinto em Cruz Elevado (LCE), um modelo animal tradicional de ansiedade. Adicionalmente, investigou-se a participação de ambas as estruturas na expressão do comportamento de desligar uma luz de intensidade aversiva em um novo teste de medo incondicionado (Light Switch Off Test; LSOT) recentemente proposto pelo nosso grupo. Encontramos uma clara segregação funcional entre a porção dorsal e ventral do CI, sendo a última envolvida nos comportamentos defensivos. Mecanismos GABAérgicos em ambas as estruturas influenciam a amplitude do PEA e o congelamento pós-fuga da EE, sugerindo uma relação funcional entre as duas estruturas. Já no LSOT, os resultados indicam o envolvimento de mecanismos GABAérgicos do vCI, mas não da SCPd, na modulação da resposta incondicionada à luz em ratos. Os resultados obtidos permitem ampliar o conhecimento atual sobre a neurobiologia dos estados de medo e ansiedade, em uma abordagem integrada dos mecanismos de processamento das informações sensoriais e da expressão de reações de defesa. / Unconditioned defense reactions observed in mammals are organized by the Brain Aversive System, comprising, among other structures, the dorsal periaqueductal gray matter (dPAG) and the inferior colliculus (IC). It has been proposed that the IC is part of the sensorimotor circuitry that processes aversive auditory information and the dPAG is considered the main neural substrate for the expression of defensive behaviors. Both structures are tonically regulated by the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). This work addresses the chemical mediation of GABA/Benzodiazepine (BZD) on aversive information processing in the IC and the elaboration of fear responses by dPAG. Independent groups of animals implanted with chemitrodes (electrodes attached to a guide cannula for drug injection) have been used to evaluate the IC and dPAG regarding the effects of local injections of GABAergic agents (muscimol, semicarbazide, and midazolam). Auditory evoked potentials (AEP) have been recorded in the IC as a measure of electrophysiological neuronal activation, in addition to determining the thresholds of defensive freezing and flight behaviors, using the electrical stimulation (EE) procedure in both IC and dPAG. The same pharmacological regimen of drug injections intra-dPAG and intra-CI have been applied to animals subjected to the elevated plus maze (EPM), a well-known animal model of anxiety, and also to a novel animal test for innate fear (Light Switch Off Test, LSOT) that has been developed and proposed by our group. We found a clear functional segregation between the dorsal and ventral portions of the IC, the latter being the specific collicular substrate of defensive behaviors. GABAergic mechanisms in both structures influence the amplitude of the AEP and post-stimulation freezing of EE, suggesting a functional link between the two structures. In the LSOT, our data indicate the involvement of GABAergic mechanisms of the ICv, but not the dPAG, in the modulation of the unconditioned response to light in rats. These original findings presented here contribute to broaden the current knowledge on the neurobiology of fear and anxiety, in an integrative approach of the mechanisms underlying sensory processing and the expression of defensive behaviors.

The midbrain periaqueductal gray matter (PAG) is an important brain region for the coordination of μ-opioid-induced pharmacological actions. The present study was designed to determine whether newly isolated μ-opioid peptide endomorphins can activate G proteins through μ-opioid receptors in the PAG by monitoring the binding to membranes of the non-hydrolyzable analog of GTP, guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS). An autoradiographic [35S]GTPγS binding study showed that both endomorphin-1 and -2 produced similar anatomical distributions of activated G proteins in the mouse midbrain region. In the mouse PAG, endomorphin-1 and -2 at concentrations from 0.001 to 10 μM increased [35S]GTPγS binding in a concentration-dependent manner and reached a maximal stimulation of 74.6 ± 3.8 and 72.3 ± 4.0%, respectively, at 10 μM. In contrast, the synthetic selective μ-opioid receptor agonist [D-Ala2,NHPhe4,Gly-ol]enkephalin (DAMGO) had a much greater efficacy and produced a 112.6 ± 5.1% increase of the maximal stimulation. The receptor specificity of endomorphin-stimulated [35S]GTPγS binding was verified by coincubating membranes with endomorphins in the presence of specific μ-, δ- or κ-opioid receptor antagonists. Coincubation with selective μ-opioid receptor antagonists β- funaltrexamine or D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Phe-Thr-NH2 (CTOP) blocked both endomorphin-1 and-2-stimulated [35S]GTPγS binding. In contrast, neither δ- nor κ-opioid receptor antagonist had any effect on the [35S]GTPγS binding stimulated by either endomorphin-1 or -2. These findings indicate that both endomorphin-1 and -2 increase [35S]GTPγS binding by selectively stimulating μ-opioid receptors with intrinsic activity less than that of DAMGO and suggest that these new endogenous ligands might be partial agonists for μ-opioid receptors in the mouse PAG.

Study objective - The aim was to determine whether areas in the periaqueductal grey matter, medial dorsal raphé, or ventrolateral medulla might be involved with the integration of blood pressure and heart rate during isometric exercise.Design - Cats were anaesthetised with α chloralose (75 mg·kg-1) and catheters inserted into the right jugular vein and carotid artery. Isometric contractions were generated using a microprocessor controlled stimulator and sleeve electrode around the tibial nerve. Bilateral lesions were made in the dorsal periaqueductal grey matter (P1.0, LR 2.0, HD + 1.5 mm) or two sites in the ventrolateral medulla (P12.0, RL 2.0, HD -10 mm; or P12.0, RL 2.0, HD -8.5 mm). Lesions were also made in the medial dorsal raphé nuclei (P1.0, RL 0.0, HD +1.5 mm). Clonidine was injected into the cerebral aqueduct to determine whether it would exert an antipressor effect during muscle contraction after the lesions were made. Only one site of lesion was made in a group of animals. Bilateral injections of clonidine (250 ng in 0.5 μl) were made into the intact ventrolateral medulla (P11.5, RL 4.0, HD -8.5 mm) to explore its role further. Fatiguing contractions were performed before and after the lesions were made, or clonidine was injected, and changes in arterial blood pressure and heart rate were measured. Verification of the lesion sites or the microinjection sites, and the extent of the lesion or spread of the clonidine, was made from histological examination of brain tissue after each experiment.Experimental material - Adult cats of either sex, n = 20, weight 2.4 (SD 0.4) kg, were used.Measurements and main results - Fatiguing isometric contractions in control conditions caused mean arterial pressure to increase by 45-50 mm Hg and heart rates by 20-25 beats·min-1. Bilateral lesions in the dorsal periaqueductal grey matter did not alter resting mean arterial pressure but attenuated the pressor response during contractions. Injections of clonidine into the cerebral aqueduct had no further antipressor effects after the lesions. Lesions of the medial dorsal raphé nuclei or injections of clonidine into the intact medial dorsal raphé nuclei did not affect the pressor response to fatiguing isometric contractions. Injections of clonidine into the intact ventrolateral medulla eliminated the pressor response to isometric contractions. Bilateral lesions of the ventrolateral medulla near the rostral lateral border of the inferior olivary tract nuclei (P12.0, LR 2.0, HD -10 mm) also attenuated the muscle pressor response, while subsequent injections of clonidine into the cerebral aqueduct depressed the changes in blood pressure further.Conclusions - Ergoreceptor information may be processed through the periaqueductal grey matter through the ventrolateral medulla to control arterial blood pressure during isometric exercise to fatigue.

A doença de Parkinson (DP) é uma desordem neurodegenerativa caracterizada clinicamente por tremor, rigidez, acinesia (ou bradicinesia) e instabilidade postural. Patofisiologicamente, a DP é classificada como uma sinucleinopatia associada à perda de neurônios dopaminérgicos na substância negra (SN), mas outros neurônios do tronco encefálico podem estar degenerados na DP, contribuindo não só para as alterações motoras, mas também não motoras observadas. Dentre as alterações não motoras, as alterações respiratórias estão presentes tais como obstrução das vias aéreas superiores, pneumonia e ainda a apnéia obstrutiva do sono uma das principais causas de morte na DP. Os mecanismos que levam à degeneração de neurônios envolvidos no controle respiratório ainda não estão bem esclarecidos, mas dados recentes do nosso laboratório mostraram que no modelo de DP induzido pela injeção no caudado-putâmen (CPu) de 6-hidroxidopamina (6-OHDA), um agente neurotóxico seletivo para células catecolaminérgicas, observou-se intensa redução na frequência respiratória e ventilação basais e induzidas pela ativação do quimiorreflexo central por hipercapnia. Além disso, observou-se também intensa redução do número de neurônios bulbares envolvidos no controle neural da respiração, como os neurônios Phox2b+ da região do núcleo retrotrapezóide (RTN), que estão envolvidos com a inspiração e o quimiorreflexo central. Dessa forma, o objetivo do presente trabalho foi investigar se a existência de uma via entre os neurônios da SN e do RTN poderia ser responsável por essa neurodegeneração. Realizamos injeções de traçadores anterógrados e retrógrados na SN e no RTN de ratos para verificar a existência de projeções diretas entre essas regiões, entretanto observamos que não há projeções diretas entre a SN e o RTN, mas há projeções indiretas entre essas duas regiões, utilizando a Substância Cinzenta Periaquedutal (PAG) como região intermediária. Além disso, observamos que no modelo de DP induzido pela injeção bilateral de 6-OHDA no CPu ocorre uma redução no número de varicosidades catecolaminérgicas na PAG e de neurônios que são ativados pelo quimiorreflexo central que se projetam da PAG para o RTN. Nossos experimentos eletrofisiológicos mostraram que a inibição bilateral da PAG pela injeção de muscimol não gera alterações respiratórias basais como ocorre no modelo da DP; entretanto, nesses animais, pudemos também observar, apesar de ser menor do que ocorre com animais submetidos ao modelo da DP, inibição de alterações respiratórias induzidas por hipercapnia. Nossos dados anatômicos mostraram que a comunicação entre os neurônios da SN e do RTN envolve neurônios da PAG e que essa via pode estar reduzida no modelo da DP, o que pode contribuir para a redução de neurônios do RTN; e que a redução neuronal desta via pode alterar as respostas respiratórias frente à ativação do quimiorreflexo central. / Parkinson\'s disease (PD) is a neurodegenerative disorder characterized clinically by tremor, rigidity, akinesia (or bradykinesia) and postural instability. Pathophysiologically, PD is classified as a synucleinopathy predominantly associated with loss of dopaminergic neurons in the substantia nigra (SN), but other brainstem neurons may also be degenerate in PD, contributing not only to the motor but also non-motor alterations observed in this pathology. Among the non-motor changes observed respiratory changes are present and can be characterized as upper airway obstruction, pneumonia and obstructive sleep apnea are one of the main causes of death in PD. The mechanisms that lead to the degeneration of neurons involved in respiratory control are still not well understood but data in the literature have demonstrated the loss of receptors in a region considered to be the respiratory rate generator in postmortem brains of humans. In the model animal DP of 6-hydroxydopamine (6-OHDA), a selective neurotoxic agent for catecholaminergic cells, there was an intense reduction in basal respiratory rate and ventilation, in addition to a intense reduction of neurons involved in neural control of breathing: Phox2b+ neurons in the retrotrapezoid nucleus (RTN) region. Thus, the aim of the present study was to investigate whether the existence of a pathway between SN and RTN neurons could be responsible for this bulbar neurodegeneration. We performed experiments using the injection of anterograde and retrograde tracers in the SN and the RTN to verify the existence of direct projections between these regions in rats. However, our results showed that there are no direct projections between the SN and the RTN, but there are indirect projections between these two regions, using Periaquedutal Gray Substance (PAG) as the intermediate region. In addition, we observed that in the PD model induced by the bilateral injection of 6-OHDA in CPu, a reduction of the projections PAG neurons for RTN and that are activated by the central chemoreflex. Our electrophysiological experiments have shown that in the 6-OHDA PD model there is a reduction of the cardiorespiratory responses induced by the activation of the central chemoreflex, since the bilateral inhibition of the PG of control animals does not alter these cardiorespiratory responses. Therefore, our anatomical results showed that the communication between SN and RTN neurons involves PAG neurons and that this pathway may be reduced in the PD model, which may contribute to the reduction of RTN neurons; and that the neuronal reduction of this pathway may alter respiratory responses to activation of the central chemoreflex.

O congelamento a um contexto previamente associado ao choque nas patas é atenuado pela lesão da matéria cinzenta periaquedutal ventrolateral (MCPvl). Por outro lado, a estimulação elétrica ou microinjeção de compostos que diminuem a neurotransmissão GABAérgica na matéria cinzenta dorsolateral (MCPdl) provocam congelamento e fuga. O presente estudo examinou a possibilidade deste congelamento provocado pela estimulação da MCPdl ser resultado da ativação indireta da MCPvl. Ratos com lesão da MCPvl ou falsooperados foram eletricamente estimulados na MCPdl para a aferição dos limiares de resposta para o congelamento e a fuga. Os mesmos animais foram também submetidos ao condicionamento aversivo ao contexto através de choque nas patas, visando a validação de nossas condições experimentais. Um segundo grupo de ratos lesados e falso-operados receberam microinjeções de semicarbazida, um bloqueador da síntese do GABA, na MCPdl. Os resultados mostram que a lesão da MCPvl atenua o congelamento condicionado ao contexto, mas é ineficaz em alterar os efeitos da estimulação elétrica ou química da MCPdl sobre o congelamento e a fuga. A MCPvl é o alvo preferencial do núcleo central da amígdala na MCP, enquanto que a MCPdl recebe aferências principalmente dos núcleos do hipotálamo relacionados à defesa. Estas evidências são coerentes com a participação da MCPvl nas respostas de defesa ao perigo potencial, e da MCPdl ao perigo imediato. / Freezing to a context previously associated to footshock is attenuated by ventrolateral periaqueductal gray (vlPAG) lesion. Moreover, electrical stimulation or microinfusion of compounds that interfere with GABA neurotransmission in the dorsolateral periaqueductal gray (dlPAG) provoke freezing and escape. The present study examined the possibility of this freezing being the result of an indirect activation of vlPAG through dlPAG stimulation. Rats bearing vlPAG or sham lesions were electrically stimulated at dlPAG sites to have their freezing and escape threshold currents measured. The same animals were also submitted to a contextual fear-conditioning paradigm through footshock to validate our experimental setting. A second group of vlPAG- and sham-lesion rats received infusions of semicarbazide, a GABA-synthesis blocker, in the MCPdl. The results obtained show that vlPAG lesions do attenuate conditioned freezing, but are ineffective against dlPAG-stimulation freezing and escape. The vlPAG is the main PAG target to central nucleus of amygdala projections, while the dlPAG receives afferents primarily from hypothalamic nuclei related to defense. This evidence is coherent with vlPAG mediating responses to potential danger, while dlPAG would be more related to immediate danger.